Holen Sie sich die Stockscreener-App
47.20
2.03%
-0.98
Handel nachbörslich:
47.01
-0.19
-0.40%
Nektar Therapeutics Aktie (NKTR) Neueste Nachrichten
Nuveen LLC Makes New $222,000 Investment in Nektar Therapeutics $NKTR - MarketBeat
Why Nektar Therapeutics Rippled Higher This Week - MSN
Invesco Ltd. Has $424,000 Holdings in Nektar Therapeutics $NKTR - MarketBeat
Nektar Therapeutics launches proposed public offering - MSN
Nektar Therapeutics (NASDAQ:NKTR) CEO Howard Robin Sells 5,166 Shares - MarketBeat
Nektar Therapeutics (NASDAQ:NKTR) CEO Howard Robin Sells 6,666 Shares - MarketBeat
Ieq Capital LLC Acquires 535,244 Shares of Nektar Therapeutics $NKTR - MarketBeat
Nektar Therapeutics (NASDAQ:NKTR) Trading 7.3% HigherTime to Buy? - MarketBeat
Nektar jumps after Sanofi data misses expectations - MSN
Nektar Therapeutics (NASDAQ:NKTR) Stock Rockets 92% As Investors Are Less Pessimistic Than Expected - 富途牛牛
Nektar says Rezolve-AD phase 2b results for rezpegaldesleukin selected for oral presentation at EADV 2025 - MarketScreener
Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025 - PR Newswire
Nektar Therapeutics chief R&D officer sells $57,692 in stock By Investing.com - Investing.com Nigeria
Nektar Therapeutics chief R&D officer sells $57,692 in stock - Investing.com India
Nektar Therapeutics CEO sells $430k in stock - Investing.com
Nektar Therapeutics to Webcast Participation in H.C. Wainwright and Stifel Healthcare Conferences in September 2025 - geneonline.com
Will Nektar Therapeutics outperform the market in YEARJuly 2025 Volume & Stock Market Timing Techniques - beatles.ru
Sanofi’s ‘disappointing’ atopic dermatitis data sends Nektar higher - MSN
NKTR Shares Surge 38.2% in a Week: Here's What You Should Know - sharewise.com
Fibonacci Retracement Aligns with Support in Nektar TherapeuticsWeekly Trade Report & Precise Entry and Exit Recommendations - beatles.ru
Restoring Immune Balance: The Next Wave Of T Cell-Targeted Therapeutics - insights.citeline.com
Almitas Capital LLC Purchases 3,690,647 Shares of Nektar Therapeutics $NKTR - MarketBeat
Is Nektar Therapeutics still a buy after recent gains2025 Valuation Update & Free Risk Controlled Daily Trade Plans - beatles.ru
Charles Schwab Investment Management Inc. Has $975,000 Stake in Nektar Therapeutics $NKTR - MarketBeat
Can Nektar Therapeutics recover in the next quarter2025 Geopolitical Influence & Community Verified Trade Signals - Newser
What’s the beta of Nektar Therapeutics stockJuly 2025 Summary & Weekly Top Gainers Alerts - خودرو بانک
What is the dividend yield of Nektar TherapeuticsWatch List & Pattern Based Trade Signal System - خودرو بانک
Measuring Nektar Therapeutics’s beta against major indicesJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
Top chart patterns to watch in Nektar TherapeuticsWeekly Stock Recap & Weekly Setup with ROI Potential - Newser
Real time alert setup for Nektar Therapeutics performanceJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - Newser
What is Nektar Therapeutics’s TAM (Total Addressable Market)July 2025 Short Interest & Free Real-Time Market Sentiment Alerts - خودرو بانک
Nektar Therapeutics stock trend forecast2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Nektar Therapeutics (NKTR) Surges on Rival's Disappointing Resul - GuruFocus
Combining machine learning predictions for Nektar TherapeuticsMarket Sentiment Report & Weekly Setup with High ROI Potential - Newser
Here's Why Shares in PTC Therapeutics Soared This Week - AOL.com
What does recent volatility data suggest for Nektar TherapeuticsJuly 2025 Summary & Real-Time Volume Triggers - Newser
Nektar Therapeutics stock jumps after Sanofi’s amlitelimab data disappoints By Investing.com - Investing.com Nigeria
Nektar Therapeutics (NKTR) Surges 26.02% as Sanofi's Underwhelming AD Trial Highlights Competitive Edge - AInvest
Candlestick signals on Nektar Therapeutics stock todayPrice Action & Precise Entry and Exit Recommendations - Newser
News impact scoring models applied to Nektar TherapeuticsJuly 2025 Summary & Daily Stock Trend Reports - Newser
Insider Sell: Jonathan Zalevsky Sells Shares of Nektar Therapeutics (NKTR) - GuruFocus
Long term hold vs stop loss in Nektar Therapeutics2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
Can Nektar Therapeutics expand into new marketsEarnings Risk Summary & Reliable Volume Spike Alerts - خودرو بانک
Analysts postive on Nektar opportunity after Sanofi data - Investing.com
What's Going On With Nektar Therapeutics Stock On Thursday? - Benzinga
Nektar Therapeutics Surges 19.5%: What's Fueling the Sharp Intraday Move? - AInvest
Nektar Therapeutics Soars 23.4% on FDA Fast Track Designation and Analyst Upgrades—Can This Momentum Sustain? - AInvest
Nektar Therapeutics to Participate in Two Investor Conferences in September - Eastern Progress
1.44%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):